These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7582250)

  • 1. Number and ultrastructure of epithelial cells in crypts and villi along the streptozotocin-diabetic small intestine: a quantitative study on the effects of insulin and aldose reductase inhibition.
    Zoubi SA; Williams MD; Mayhew TM; Sparrow RA
    Virchows Arch; 1995; 427(2):187-93. PubMed ID: 7582250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Responses of enterocyte microvilli in experimental diabetes to insulin and an aldose reductase inhibitor (ponalrestat).
    Williams M; Mayhew TM
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(6):385-9. PubMed ID: 1360726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small intestinal morphology in experimental diabetic rats: a stereological study on the effects of an aldose reductase inhibitor (ponalrestat) given with or without conventional insulin therapy.
    Mayhew TM; Carson FL; Sharma AK
    Diabetologia; 1989 Sep; 32(9):649-54. PubMed ID: 2676666
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The small intestine in experimental diabetes: cellular adaptation in crypts and villi at different longitudinal sites.
    Zoubi SA; Mayhew TM; Sparrow RA
    Virchows Arch; 1995; 426(5):501-7. PubMed ID: 7633660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrastructural observations on myelinated fibres in experimental diabetes: effect of the aldose reductase inhibitor ponalrestat given alone or in conjunction with insulin therapy.
    Bhoyrul S; Sharma AK; Stribling D; Mirrlees DD; Peterson RG; Farber MO; Thomas PK
    J Neurol Sci; 1988 Jun; 85(2):131-47. PubMed ID: 2968441
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric neuropeptides in streptozotocin-diabetic rats; effects of insulin and aldose reductase inhibition.
    Belai A; Calcutt NA; Carrington AL; Diemel LT; Tomlinson DR; Burnstock G
    J Auton Nerv Syst; 1996 May; 58(3):163-9. PubMed ID: 8738309
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term aldose reductase inhibition on development of experimental diabetic neuropathy. Ultrastructural and morphometric studies of sural nerve in streptozocin-induced diabetic rats.
    Yagihashi S; Kamijo M; Ido Y; Mirrlees DJ
    Diabetes; 1990 Jun; 39(6):690-6. PubMed ID: 2140802
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired induction of nerve ornithine decarboxylase activity in the streptozotocin-diabetic rat is prevented by the aldose reductase inhibitor ponalrestat.
    Pekiner C; McLean WG
    Br J Pharmacol; 1990 Dec; 101(4):978-80. PubMed ID: 2128196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of aldose reductase inhibitors on glomerular prostaglandin production and urinary albumin excretion in experimental diabetes mellitus.
    Chang WP; Dimitriadis E; Allen T; Dunlop ME; Cooper M; Larkins RG
    Diabetologia; 1991 Apr; 34(4):225-31. PubMed ID: 1906023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of aldose reductase inhibition with ponalrestat on changes in vascular function in streptozotocin diabetic rats.
    Otter DJ; Chess-Williams R
    Br J Pharmacol; 1994 Oct; 113(2):576-80. PubMed ID: 7834210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contractile properties of cardiac papillary muscle in streptozotocin-diabetic rats and the effects of aldose reductase inhibition.
    Cameron NE; Cotter MA; Robertson S
    Diabetologia; 1989 Jun; 32(6):365-70. PubMed ID: 2503412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of adaptation in rat small intestine: regional differences in quantitative morphology during normal growth and experimental hypertrophy.
    Mayhew TM; Carson FL
    J Anat; 1989 Jun; 164():189-200. PubMed ID: 2532638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired nerve regeneration in streptozotocin-diabetic rats. Effects of treatment with an aldose reductase inhibitor.
    Ekström AR; Tomlinson DR
    J Neurol Sci; 1989 Nov; 93(2-3):231-7. PubMed ID: 2531788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial function in the isolated perfused mesentery and aortae of rats with streptozotocin-induced diabetes: effect of treatment with the aldose reductase inhibitor, ponalrestat.
    Taylor PD; Wickenden AD; Mirrlees DJ; Poston L
    Br J Pharmacol; 1994 Jan; 111(1):42-8. PubMed ID: 8012723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striated brush border of intestinal absorptive epithelial cells: stereological studies on microvillous morphology in different adaptive states.
    Mayhew TM
    J Electron Microsc Tech; 1990 Sep; 16(1):45-55. PubMed ID: 2213231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crypt and villous epithelial cells in adult rat small intestine: numerical and volumetric variation along longitudinal and vertical axes.
    Zoubi SA; Mayhew TM; Sparrow RA
    Epithelial Cell Biol; 1994 Jul; 3(3):112-8. PubMed ID: 7894568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relative importance of aldose reductase versus nonenzymatic glycosylation on sugar cataract formation in diabetic rats.
    Kador PF; Lee JW; Fujisawa S; Blessing K; Lou MF
    J Ocul Pharmacol Ther; 2000 Apr; 16(2):149-60. PubMed ID: 10803425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ponalrestat: a potent and specific inhibitor of aldose reductase.
    Ward WH; Sennitt CM; Ross H; Dingle A; Timms D; Mirrlees DJ; Tuffin DP
    Biochem Pharmacol; 1990 Jan; 39(2):337-46. PubMed ID: 2105733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crypts, villi and microvilli in the small intestine of the rat. A stereological study of their variability within and between animals.
    Mayhew TM; Middleton C
    J Anat; 1985 Aug; 141():1-17. PubMed ID: 4077708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissociation between biochemical and functional effects of the aldose reductase inhibitor, ponalrestat, on peripheral nerve in diabetic rats.
    Cameron NE; Cotter MA
    Br J Pharmacol; 1992 Dec; 107(4):939-44. PubMed ID: 1467842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.